Huntsman and Zamil Group Plan New Morpholine and Diglycolamine® Agent Joint Venture in Saudi Arabia
Huntsman Corporation and the Zamil Group Holding Company signed a non-binding memorandum of understanding (MoU) to explore the feasibility of constructing and operating a morpholine and Diglycolamine® Agent (DGA) amines joint venture in Jubail, Saudi Arabia.
According to the MoU, the joint venture would operate the proposed plant on a 50:50 basis and would use technology licensed from Huntsman, with Huntsman also having the rights to global sales and marketing of products produced at the plant.
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Category:Singaporean_chemists

PROGEO Monitoring GmbH - Großbeeren, Germany

PSL Systemtechnik GmbH - Clausthal-Zellerfeld, Germany
It takes more than an active ingredient to make a medicine

Spiders spin unique phononic material
Hybrid copper-gold nanoparticles convert CO2 - May reduce greenhouse gas emissions
